A low-fat, high-complex carbohydrate diet supplemented with long-chain (n-3) fatty acids alters the postprandial lipoprotein profile in patients with metabolic syndrome

Journal of Nutrition

Volumn 140, Issue 9, 2010, Pages 1595-1601

  Jiménez Gómez, Yolanda ^a   Marín, Carmen ^a   Pérez Martínez, Pablo ^a   Hartwich, Jadwiga ^b   Malczewska Malec, Malgorzata ^b   Golabek, Iwona ^b   Kieć Wilk, Beata ^b   Cruz Teno, Cristina ^a   Rodríguez, Fernando ^c   Gómez, Purificación ^a   Gómez Luna, Maria J ^a   Defoort, Catherine ^d   Gibney, Michael J ^e   Pérez Jiménez, Francisco ^a   Roche, Helen M ^e   López Miranda, José ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d INSERM   (France)

^e UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN B48; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LIPOPROTEIN; LONG CHAIN FATTY ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; PLACEBO; RETINOL PALMITATE; SUNFLOWER OIL; TRIACYLGLYCEROL;

ARTICLE; CARBOHYDRATE DIET; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; FAT INTAKE; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTICENTER STUDY; POSTPRANDIAL STATE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

DIETARY CARBOHYDRATES; DIETARY FATS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POSTPRANDIAL PERIOD;

HELIANTHUS;

EID: 77956604044     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.109.120816     Document Type: Article

References (48)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). JAMA. 2001;285:2486-97.
3. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; National Heart, Lung, and Blood Institute, American Heart Association. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004;24:e13-8.
4. Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation. 2002;106:286-8.
5. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112:2735-52.
6. Phillips C, Lopez-Miranda J, Perez-Jimenez F, McManus R, Roche HM. Genetic and nutrient determinants of the metabolic syndrome. Curr Opin Cardiol. 2006;21:185-93. (Pubitemid 44315081)
7. Liese AD, Roach AK, Sparks KC, Marquart L, D'Agostino RB Jr, Mayer-Davis EJ. Whole-grain intake and insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Am J Clin Nutr. 2003;78:965-71. (Pubitemid 39663473)
8. Pereira MA, Jacobs DR Jr, Van Horn L, Slattery ML, Kartashov AI, Ludwig DS. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA. 2002;287: 2081-9. (Pubitemid 34437343)
9. Garg A, Bonanome A, Grundy SM, Zhang ZJ, Unger RH. Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 1988;319:829-34.
10. Roche HM, Gibney MJ. Postprandial triacylglycerolaemia: the effect of low-fat dietary treatment with and without fish oil supplementation. Eur J Clin Nutr. 1996;50:617-24.
11. Lopez-Miranda J, Williams C, Lairon D. Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br J Nutr. 2007;98:458-73. (Pubitemid 47272862)
12. Ruotolo G, Howard BV. Dyslipidemia of the metabolic syndrome. Curr Cardiol Rep. 2002;4:494-500.
13. Giugliano D, Ceriello A, Esposito K. Are there specific treatments for the metabolic syndrome? Am J Clin Nutr. 2008;87:8-11.
14. Volek JS, Phinney SD, Forsythe CE, Quann EE, Wood RJ, Puglisi MJ, Kraemer WJ, Bibus DM, Fernandez ML, et al. Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids. 2009;44:297-309.
15. Shaw DI, Tierney AC, McCarthy S, Upritchard J, Vermunt S, Gulseth HL, Drevon CA, Blaak EE, Saris WH. LIPGENE food-exchange model for alteration of dietary fat quantity and quality in free-living participants from eight European countries. Br J Nutr. 2009;101:750-9.
16. Harris WS, Pottala JV, Sands SA, Jones PG. Comparison of the effects of fish and fish-oil capsules on the n-3. Am J Clin Nutr. 2007;86:1621-5.
17. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19:476-82.
18. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-5.
19. Riepponen P, Marniemi J, Rautaoja T. Immunoturbidimetric determination of apolipoproteins A-1 and B in serum. Scand J Clin Lab Invest. 1987;47:739-44. (Pubitemid 18002120)
20. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1379-88. (Pubitemid 12125081)
21. Kinoshita M, Kojima M, Matsushima T, Teramoto T. Determination of apolipoprotein B-48 in serum by a sandwich ELISA. Clin Chim Acta. 2005;351:115-20. (Pubitemid 39563564)
22. Ruotolo G, Zhang H, Bentsianov V, Le NA. Protocol for the study of the metabolism of retinyl esters in plasma lipoproteins during postprandial lipemia. J Lipid Res. 1992;33:1541-9.
23. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-9. (Pubitemid 32893993)
24. Iovine C, Gentile A, Hattemer A, Pacioni D, Riccardi G, Rivellese AA. Self- monitoring of plasma triglyceride levels to evaluate postprandial response to different nutrients. Metabolism. 2004;53:620-3.
25. Vessby B. Dietary fat and insulin action in humans. Br J Nutr. 2000; 83 Suppl 1:S91-6.
26. Connor WE. Importance of n-3 fatty acids in health and disease. Am J Clin Nutr. 2000;71 Suppl 1:171S-5S.
27. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F. Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adults. Am J Clin Nutr. 2005;82:523-30. (Pubitemid 43759235)
28. McKeown NM. Whole grain intake and insulin sensitivity: evidence from observational studies. Nutr Rev. 2004;62:286-91.
29. Salas-Salvadó J, Fernández-Ballart J, Ros E, Martínez-Gonzá lez MA, Fitó M, Estruch R, Corella D, Fiol M, Gó mez-Gracia E, et al. Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial. Arch Intern Med. 2008;168:2449-58.
30. Feskens EJ, Virtanen SM, Räsänen L, Tuomilehto J, Stengård J, Pekkanen J, Nissinen A, Kromhout D. Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care. 1995;18:1104-12.
31. Sacks FM, Katan M. Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am J Med. 2002;113 Suppl 9B:S13-24.
32. Aarsland A, Chinkes D, Wolfe RR. Hepatic and whole-body fat synthesis in humans during carbohydrate overfeeding. Am J Clin Nutr. 1997;65:1774-82. (Pubitemid 27240693)
33. McNeel RL, Mersmann HJ. Low- and high-carbohydrate diets: body composition differences in rats. Obes Res. 2005;13:1651-60.
34. Grundy SM. Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. N Engl J Med. 1986;314: 745-8.
35. Riccardi G, Giacco R, Rivellese AA. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr. 2004;23:447-56. (Pubitemid 39107022)
36. Vessby B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr Opin Lipidol. 2003;14:15-9. (Pubitemid 36183096)
37. Kolovou GD, Anagnostopoulou KK, Pavlidis AN, Salpea KD, Iraklianou SA, Tsarpalis K, Damaskos DS, Manolis A, Cokkinos DV. Postprandial lipemia in men with metabolic syndrome, hypertensives and healthy subjects. Lipids Health Dis. 2005;4:21.
38. Zampelas A, Roche H, Knapper JM, Jackson KG, Tornaritis M, Hatzis C, Gibney MJ, Kafatos A, Gould BJ, et al. Differences in postprandial lipaemic response between Northern and Southern Europeans. Atherosclerosis. 1998;139:83-93. (Pubitemid 28341870)
39. Roche HM, Zampelas A, Knapper JM, Webb D, Brooks C, Jackson KG, Wright JW, Gould BJ, Kafatos A, et al. Effect of long-term olive oil dietary intervention on postprandial triacylglycerol and factor VII metabolism. Am J Clin Nutr. 1998;68:552-60. (Pubitemid 28402376)
40. Silva KD, Kelly CN, Jones AE, Smith RD, Wootton SA, Miller GJ, Williams CM. Chylomicron particle size and number, factor VII activation and dietary monounsaturated fatty acids. Atherosclerosis. 2003;166: 73-84.
41. Dashti N, Smith EA, Alaupovic P. Increased production of apolipoprotein B and its lipoproteins by oleic acid in Caco-2 cells. J Lipid Res. 1990;31:113-23. (Pubitemid 20038152)
42. Berglund L, Lefevre M, Ginsberg HN, Kris-Etherton PM, Elmer PJ, Stewart PW, Ershow A, Pearson TA, Dennis BH, et al. Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am J Clin Nutr. 2007;86:1611-20.
43. Kafatos A, Comas GE. Biological effect of olive oil in human health. In: Kiritsakis A, editor. Olive oil. Champaign (IL): American Oil Chemists Society; 1990. p. 157-81.
44. Roche HM, Gibney MJ. Effect of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism. Am J Clin Nutr. 2000;71 Suppl 1:S232-7.
45. Collier GR, Sinclair AJ. Role of N-6 and N-3 fatty acids in the dietary treatment of metabolic disorders. Ann N Y Acad Sci. 1993;683:322-30.
46. Harris WS, Connor WE, Alam N, Illingworth DR. Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids. J Lipid Res. 1988;29:1451-60. (Pubitemid 19013039)
47. Clarke SD, Jump D. Polyunsaturated fatty acids regulate lipogenic and peroxisomal gene expression by independent mechanisms. Prostaglandins Leukot Essent Fatty Acids. 1997;57:65-9. (Pubitemid 27300220)
48. Harris WS, Lu G, Rambjor GS, Walen AI, Ontko JA, Cheng Q, Windsor SL. Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases. Am J Clin Nutr. 1997;66:254-60. (Pubitemid 27360322)